Re-evaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates.

Re-evaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates. by Cormican MG and Jones RN published in Diagn. Microbiol. Infect. Dis. 1995; 21 (4): 227-230

Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.

Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam. by Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1995; 21 (1): 57-60

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against Gram-positive aerobic organisms and anaerobes.

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against Gram-positive aerobic organisms and anaerobes. by Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 1995; 39 (7): 1636-1642

North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.

North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group. by Jones RN and Hoban DJ published in Diagn. Microbiol. Infect. Dis. 1994; 18 (1): 49-56

Interpretive criteria for DU-6859a disk diffusion tests using 5- micrograms disks.

Interpretive criteria for DU-6859a disk diffusion tests using 5- micrograms disks. by Jones RN, Johnson DM and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 18 (2): 125-127

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. by Jones RN, Doern GV, Gerlach EH, Hindler J and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 18 (4): 243-249

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: Real or perceived? Fluoroquinolone Resistance Surveillance Group.

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: Real or perceived? Fluoroquinolone Resistance Surveillance Group. by Jones RN, Kehrberg EN, Erwin ME and Anderson SC published in Diagn. Microbiol. Infect. Dis. 1994; 19 (4): 203-215

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group. by Jones RN, Sader HS and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 20 (2): 93-98

Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.

Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results. by Jones RN, Sutton LD, Cantrell HF and Lankford RB published in Diagn. Microbiol. Infect. Dis. 1994; 20 (3): 143-149

Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.

Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. by Houston AK and Jones RN published in Diagn. Microbiol. Infect. Dis. 1994; 18 (1): 57-59